title: Setting high-impact clinical research priorities for the Society for Vascular Surgery.
abstract: With the overall goal of enhancing the effectiveness and efficiency of vascular care, the Society for Vascular Surgery (SVS) recently completed a process by which it identified its top clinical research priorities to address critical gaps in knowledge guiding practitioners in prevention and treatment of vascular disease. After a survey of the SVS membership, a panel of SVS committee members and opinion leaders considered 53 distinct research questions through a structured process that resulted in identification of nine clinical issues that were felt to merit immediate attention by vascular investigators and external funding agencies. These are, in order of priority: (1) define optimal management of asymptomatic carotid stenosis, (2) compare the effectiveness of medical vs invasive treatment (open or endovascular) of vasculogenic claudication, (3) compare effectiveness of open vs endovascular infrainguinal revascularization as initial treatment of critical limb ischemia, (4) develop and compare the effectiveness of clinical strategies to reduce cardiovascular and other perioperative complications (eg, wound) after vascular intervention, (5) compare the effectiveness of strategies to enhance arteriovenous fistula maturation and durability, (6) develop best practices for management of chronic venous ulcer, (7) define optimal adjunctive medical therapy to enhance the success of lower extremity revascularization, (8) identify and evaluate medical therapy to prevent abdominal aortic aneurysm growth, and (9) evaluate ultrasound vs computed tomographic angiography surveillance after endovascular aneurysm repair.
authors: Research Council, Society for Vascular Surgery, Chicago, IL 60611, USA. larry.kraiss@hsc.utah.edu
authors: Larry W
authors: LW
authors: Kraiss
authors: Michael S
authors: MS
authors: Conte
authors: Randolph L
authors: RL
authors: Geary
authors: Melina
authors: M
authors: Kibbe
authors: C Keith
authors: CK
authors: Ozaki
mesh_terms: D035843:Biomedical Research / Q000191:economics / Q000458:organization & administration; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D057186:Comparative Effectiveness Research / Q000191:economics / Q000458:organization & administration; D003952:Diagnostic Imaging / Q000379:methods; D057510:Endovascular Procedures; D006292:Health Priorities / Q000191:economics / Q000458:organization & administration; D006801:Humans; D009937:Organizational Objectives; D012109:Research Support as Topic; D012955:Societies, Medical; D011795:Surveys and Questionnaires; D014652:Vascular Diseases / Q000175:diagnosis / Q000628:therapy*; D014656:Vascular Surgical Procedures / Q000009:adverse effects / Q000458:organization & administration
chemical_list: D002317:Cardiovascular Agents